CN106805234A - A kind of anti-trioxypurine food compositions - Google Patents
A kind of anti-trioxypurine food compositions Download PDFInfo
- Publication number
- CN106805234A CN106805234A CN201611177388.8A CN201611177388A CN106805234A CN 106805234 A CN106805234 A CN 106805234A CN 201611177388 A CN201611177388 A CN 201611177388A CN 106805234 A CN106805234 A CN 106805234A
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- trioxypurine
- uric acid
- food compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 32
- 235000013305 food Nutrition 0.000 title claims abstract description 26
- 239000000843 powder Substances 0.000 claims abstract description 47
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 17
- 244000068988 Glycine max Species 0.000 claims abstract description 15
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 15
- 241000251468 Actinopterygii Species 0.000 claims abstract description 13
- 244000197580 Poria cocos Species 0.000 claims abstract description 13
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 13
- 240000003915 Lophatherum gracile Species 0.000 claims abstract description 12
- 102000015636 Oligopeptides Human genes 0.000 claims abstract description 11
- 108010038807 Oligopeptides Proteins 0.000 claims abstract description 11
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 18
- 235000005979 Citrus limon Nutrition 0.000 claims description 9
- 244000131522 Citrus pyriformis Species 0.000 claims description 9
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 7
- 239000004376 Sucralose Substances 0.000 claims description 7
- 235000013399 edible fruits Nutrition 0.000 claims description 7
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 7
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 7
- 235000019408 sucralose Nutrition 0.000 claims description 7
- 235000013311 vegetables Nutrition 0.000 claims description 7
- 239000001509 sodium citrate Substances 0.000 claims description 6
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 abstract description 17
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 abstract description 17
- 229940116269 uric acid Drugs 0.000 abstract description 17
- 230000000694 effects Effects 0.000 abstract description 11
- 208000004880 Polyuria Diseases 0.000 abstract description 6
- 230000004060 metabolic process Effects 0.000 abstract description 6
- 230000035619 diuresis Effects 0.000 abstract description 5
- 201000005569 Gout Diseases 0.000 abstract description 4
- 230000029142 excretion Effects 0.000 abstract description 4
- 238000001727 in vivo Methods 0.000 abstract description 4
- 102000004169 proteins and genes Human genes 0.000 abstract description 3
- 108090000623 proteins and genes Proteins 0.000 abstract description 3
- 239000013589 supplement Substances 0.000 abstract description 3
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 229920001184 polypeptide Polymers 0.000 abstract description 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract description 2
- 238000003786 synthesis reaction Methods 0.000 abstract description 2
- 230000001133 acceleration Effects 0.000 abstract 1
- 239000000463 material Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000012467 final product Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000003387 muscular Effects 0.000 description 2
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 1
- 206010061623 Adverse drug reaction Diseases 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- OFCNXPDARWKPPY-UHFFFAOYSA-N allopurinol Chemical compound OC1=NC=NC2=C1C=NN2 OFCNXPDARWKPPY-UHFFFAOYSA-N 0.000 description 1
- 229960003459 allopurinol Drugs 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- DBABZHXKTCFAPX-UHFFFAOYSA-N probenecid Chemical compound CCCN(CCC)S(=O)(=O)C1=CC=C(C(O)=O)C=C1 DBABZHXKTCFAPX-UHFFFAOYSA-N 0.000 description 1
- 229960003081 probenecid Drugs 0.000 description 1
- 230000004144 purine metabolism Effects 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention provides a kind of anti-trioxypurine food compositions, following component is included according to parts by weight：22 28 parts of ocean fish oligopeptide powder；25 35 parts of lophatherum gracile powder；18 22 parts of Poria cocos powder；450 550 parts of Soybean Peptide.Composition of the invention has the following technical effect that：1）Uric acid is reduced, alleviates gout；2）Safety is had no side effect, and body zero is born；3）Component marine fish polypeptide can suppress the synthesis of uric acid, and lophatherum gracile can promote the excretion of uric acid with the diuresis of Poria cocos, basic metabolism ability is improved while protein needed for Soybean Peptide supplement body, with acceleration uric acid metabolism in vivo.
Description
Technical field
The present invention relates to a kind of anti-trioxypurine food compositions, belong to field of food.
Background technology
Uric acid is the end-product of purine metabolism in human body, and the daily growing amount of internal uric acid and excretion are approximately equivalent, but
When internal purine metabolic disturbance, uric acid content will be raised, and because the solubility of uric acid is small, urinary tract can be formed when excessive in vivo
Calculus or gout.
Anti-trioxypurine product is mainly medicine, such as colchicin, probenecid, Allopurinol, NSAIDs in the market
Deng.This kind of drug side-effect is relatively large, and long-term taking can develop immunity to drugs, and patient is susceptible to medication lack of standardization and shows
As causing internal uric acid to synthesize and metabolic disorder.
For food products market, anti-trioxypurine tea is commonplace, but its dispensing is mainly some diuresis compositions, it is impossible to from basic
Upper solution high lithemia symptom.
The main component that this product is used, can fundamentally suppress uric acid generation, and auxiliary material contributes to the excretion of uric acid, so that
Reach the effect for reducing internal uric acid.
The content of the invention
The purpose of the present invention is to overcome the deficiencies in the prior art, there is provided a kind of anti-trioxypurine food compositions.
Anti-trioxypurine food compositions of the invention, following component is included according to parts by weight：Ocean fish oligopeptide powder 22-28
Part；Lophatherum gracile powder 25-35 parts；Poria cocos powder 18-22 parts；Soybean Peptide 450-550 parts.
Preferably,
Described anti-trioxypurine food compositions, following component is included according to parts by weight：Ocean fish oligopeptide powder 22-28
Part；Lophatherum gracile powder 25-35 parts；Comprehensive fruit vegetable powder 12-18 parts；D-sorbite 25-35 parts；Citric acid 55-60 parts；Sodium citrate
25-35 parts；20-25 parts of lemon juice powder；Poria cocos powder 18-22 parts；Sucralose 0.5-1.5 parts, Soybean Peptide 450-550 parts.
Described anti-trioxypurine food compositions, following component is included according to parts by weight：25 parts of ocean fish oligopeptide powder；It is light
30 parts of bamboo leaf powder；15 parts of comprehensive fruit vegetable powder；30 parts of D-sorbite；58 parts of citric acid；30 parts of sodium citrate；Lemon juice powder 23
Part；20 parts of Poria cocos powder；1 part of Sucralose, 500 parts of Soybean Peptide.
The preparation method of food compositions of the invention：Each material composition is weighed according to part by weight, is dried, mixing is equal
It is even filling to obtain final product.
In the present invention, each component function is as follows：
1) ocean fish oligopeptide powder function alleviates gout to reduce uric acid；The extension muscular movement time；Increase muscular movement
Intensity；Dephlogistication phenomenon；Gastric ulcer symptom is reduced, accelerates callus；Slow down the aging powerless symptom of muscle；Strengthen nerves reaction to pass
Lead speed；Reduce myocardial ischemia and cerebral ischemic is injured, such as too high levels, can not only increase the cost of product, and its anti-trioxypurine
Effect will not also be remarkably reinforced, and as content is too low, not reach the effect of anti-trioxypurine；
2) lophatherum gracile powder has refrigerant, antipyretic, diuresis and the effect hastened parturition, and such as too high levels can increase product cost, such as content
The too low effect for not reaching diuresis；
3) Poria cocos powder can control difficult urination, oedema turgor, phlegm and retained fluid cough inverse, inverse, vomiting during early pregnancy of vomitting, diarrhea, seminal emission, stranguria with turbid discharge, palpitation with fear,
Forgetful to wait disease, such as too high levels can increase product cost, and such as content is too low does not reach diuretic effect；
4) Soybean Peptide quickly supplements protein needed for body, improves basic metabolism ability, promotes uric acid metabolism in vivo,
As too high levels increase cost, mouthfeel is influenceed, such as content is too low does not reach effect.
Composition of the invention has the following technical effect that：
1) uric acid is reduced, alleviates gout；
2) safety is had no side effect, and body zero is born；
3) component marine fish polypeptide can suppress the synthesis of uric acid, and lophatherum gracile can promote urine with the diuresis of Poria cocos
The excretion of acid, basic metabolism ability is improved needed for Soybean Peptide supplement body while protein, with accelerating uric acid in vivo
Metabolism.
Specific embodiment
In the present invention, except Soybean Peptide, remaining each composition is purchased from Shanghai Li Tong biochemical products Co., Ltd.Soybean Peptide is purchased
From promise profit such as (Beijing) bio tech ltd.
Embodiment 1
Anti-trioxypurine food compositions of the invention, consist of the following composition according to parts by weight：Ocean fish oligopeptide powder 22
Part；35 parts of lophatherum gracile powder；18 parts of comprehensive fruit vegetable powder；35 parts of D-sorbite；60 parts of citric acid；35 parts of sodium citrate；Lemon juice
25 parts of powder；22 parts of Poria cocos powder；1.5 parts of Sucralose；450 parts of Soybean Peptide.
The preparation method of food compositions of the invention：Each material composition is weighed according to part by weight, is dried, mixing is equal
It is even it is filling obtain final product, every bag of 10g.
Instructions of taking：It is soaked to drink, twice a day, one bag every time.
The anti-trioxypurine effect such as following table of the food compositions of the present embodiment：
As can be seen from the above table, the anti-trioxypurine of anti-trioxypurine food of the present invention works well.
Embodiment 2
Anti-trioxypurine food compositions of the invention, consist of the following composition according to parts by weight：Ocean fish oligopeptide powder 28
Part；25 parts of lophatherum gracile powder；12 parts of comprehensive fruit vegetable powder；25 parts of D-sorbite；55 parts of citric acid；25 parts of sodium citrate；Lemon juice
20 parts of powder；18 parts of Poria cocos powder；0.5 part of Sucralose；550 parts of Soybean Peptide.
The preparation method of food compositions of the invention：Each material composition is weighed according to part by weight, is dried, mixing is equal
It is even it is filling obtain final product, every bag of 10g.
Instructions of taking：It is soaked to drink, twice a day, one bag every time.
The anti-trioxypurine effect such as following table of the food compositions of the present embodiment：
As can be seen from the above table, the anti-trioxypurine of anti-trioxypurine food of the present invention works well.
Embodiment 3
Anti-trioxypurine food compositions of the invention, consist of the following composition according to parts by weight：Ocean fish oligopeptide powder 25
Part；30 parts of lophatherum gracile powder；15 parts of comprehensive fruit vegetable powder；30 parts of D-sorbite；58 parts of citric acid；30 parts of sodium citrate；Lemon juice
23 parts of powder；20 parts of Poria cocos powder；1 part of Sucralose；500 parts of Soybean Peptide.
The preparation method of food compositions of the invention：Each material composition is weighed according to part by weight, is dried, mixing is equal
It is even it is filling obtain final product, every bag of 10g.
Instructions of taking：It is soaked to drink, twice a day, one bag every time.
The anti-trioxypurine effect such as following table of the food compositions of the present embodiment：
As can be seen from the above table, the anti-trioxypurine of anti-trioxypurine food of the present invention works well.
Claims (3)
1. a kind of anti-trioxypurine food compositions, it is characterised in that include following component according to parts by weight：Ocean fish oligopeptide powder
22-28 parts；Lophatherum gracile powder 25-35 parts；Poria cocos powder 18-22 parts；Soybean Peptide 450-550 parts.
2. anti-trioxypurine food compositions according to claim 1, it is characterised in that according to parts by weight include it is following into
Point：22-28 parts of ocean fish oligopeptide powder；Lophatherum gracile powder 25-35 parts；Comprehensive fruit vegetable powder 12-18 parts；D-sorbite 25-35 parts；Lemon
55-60 parts of lemon acid；Sodium citrate 25-35 parts；20-25 parts of lemon juice powder；Poria cocos powder 18-22 parts；Sucralose 0.5-1.5
Part, Soybean Peptide 450-550 parts.
3. anti-trioxypurine food compositions according to claim 1, it is characterised in that according to parts by weight include it is following into
Point：25 parts of ocean fish oligopeptide powder；30 parts of lophatherum gracile powder；15 parts of comprehensive fruit vegetable powder；30 parts of D-sorbite；58 parts of citric acid；Lemon
Lemon 30 parts of sodium of acid；23 parts of lemon juice powder；20 parts of Poria cocos powder；1 part of Sucralose, 500 parts of Soybean Peptide.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611177388.8A CN106805234A (en) | 2016-12-19 | 2016-12-19 | A kind of anti-trioxypurine food compositions |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611177388.8A CN106805234A (en) | 2016-12-19 | 2016-12-19 | A kind of anti-trioxypurine food compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106805234A true CN106805234A (en) | 2017-06-09 |
Family
ID=59109761
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201611177388.8A Pending CN106805234A (en) | 2016-12-19 | 2016-12-19 | A kind of anti-trioxypurine food compositions |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106805234A (en) |
Cited By (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107951022A (en) * | 2017-12-28 | 2018-04-24 | 陆淼兴 | A kind of marine fish oligopeptide mixture and its preparation and preparation method |
| CN108065166A (en) * | 2017-12-21 | 2018-05-25 | 深圳万和制药有限公司 | Solid beverage composition with anti-trioxypurine effect |
| CN108095096A (en) * | 2017-12-29 | 2018-06-01 | 董占斌 | The composition and preparation method of a kind of anti-trioxypurine |
| CN108576367A (en) * | 2018-03-15 | 2018-09-28 | 广州海生元海洋生物科技有限公司 | Fish polypeptide dry powder, anti-trioxypurine peptide combinations, beverage containing anserine and preparation method |
| CN108719984A (en) * | 2018-05-25 | 2018-11-02 | 四川大学 | A kind of generation meal nutrition bar and preparation method thereof for gout crowd |
| CN109122859A (en) * | 2018-11-01 | 2019-01-04 | 威海健康生生物科技有限公司 | Anti-trioxypurine composition and the preparation method and application thereof |
| CN109329930A (en) * | 2018-11-02 | 2019-02-15 | 广州市臻善科技有限公司 | A kind of composition and preparation method thereof for promoting uric acid to reduce |
| CN109452521A (en) * | 2018-12-26 | 2019-03-12 | 广东养慕特殊医用食品有限公司 | A kind of anti-trioxypurine peptide solid beverage, Preparation method and use |
| CN109770141A (en) * | 2019-03-08 | 2019-05-21 | 唐凯 | A kind of drink eaten suitable for the high crowd of uric acid |
| CN109938349A (en) * | 2019-03-29 | 2019-06-28 | 宁波御坊堂生物科技有限公司 | A kind of oligomeric peptide functional food and preparation method thereof |
| CN110038119A (en) * | 2019-04-28 | 2019-07-23 | 杭州泽健医药科技有限公司 | A kind of pharmaceutical composition with anti-trioxypurine and antifatigue effect |
| CN110101656A (en) * | 2019-05-20 | 2019-08-09 | 江苏西宏生物医药有限公司 | A kind of preparation method of citric acid saline solution |
| CN110604316A (en) * | 2019-10-30 | 2019-12-24 | 山东若尧特医食品有限公司 | Protein solid preparation and preparation method thereof |
| CN112544974A (en) * | 2020-12-31 | 2021-03-26 | 汤臣倍健股份有限公司 | Composition with function of regulating uric acid metabolism and application thereof |
| CN113100443A (en) * | 2021-05-17 | 2021-07-13 | 卢静 | Composition and soft capsule for relieving gout and preparation method thereof |
| CN114947124A (en) * | 2022-04-22 | 2022-08-30 | 北京恒生药业有限公司 | Solid composition with gout relieving effect and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104758920A (en) * | 2015-04-29 | 2015-07-08 | 唐凯 | Gout health care product based on homology of medicine and food |
| CN105029447A (en) * | 2015-08-11 | 2015-11-11 | 湖南科尔生物技术有限公司 | Sea-fish oligopeptide powder containing activated probiotics |
| CN105901728A (en) * | 2016-04-21 | 2016-08-31 | 姜国辉 | Composition beneficial to postoperative rehabilitation and preparation method thereof |
-
2016
- 2016-12-19 CN CN201611177388.8A patent/CN106805234A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104758920A (en) * | 2015-04-29 | 2015-07-08 | 唐凯 | Gout health care product based on homology of medicine and food |
| CN105029447A (en) * | 2015-08-11 | 2015-11-11 | 湖南科尔生物技术有限公司 | Sea-fish oligopeptide powder containing activated probiotics |
| CN105901728A (en) * | 2016-04-21 | 2016-08-31 | 姜国辉 | Composition beneficial to postoperative rehabilitation and preparation method thereof |
Cited By (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108065166A (en) * | 2017-12-21 | 2018-05-25 | 深圳万和制药有限公司 | Solid beverage composition with anti-trioxypurine effect |
| CN107951022A (en) * | 2017-12-28 | 2018-04-24 | 陆淼兴 | A kind of marine fish oligopeptide mixture and its preparation and preparation method |
| CN108095096A (en) * | 2017-12-29 | 2018-06-01 | 董占斌 | The composition and preparation method of a kind of anti-trioxypurine |
| CN108576367A (en) * | 2018-03-15 | 2018-09-28 | 广州海生元海洋生物科技有限公司 | Fish polypeptide dry powder, anti-trioxypurine peptide combinations, beverage containing anserine and preparation method |
| CN108719984B (en) * | 2018-05-25 | 2021-09-03 | 四川大学 | Meal replacement nutrition bar for gout population and preparation method thereof |
| CN108719984A (en) * | 2018-05-25 | 2018-11-02 | 四川大学 | A kind of generation meal nutrition bar and preparation method thereof for gout crowd |
| CN109122859A (en) * | 2018-11-01 | 2019-01-04 | 威海健康生生物科技有限公司 | Anti-trioxypurine composition and the preparation method and application thereof |
| CN109329930A (en) * | 2018-11-02 | 2019-02-15 | 广州市臻善科技有限公司 | A kind of composition and preparation method thereof for promoting uric acid to reduce |
| CN109452521A (en) * | 2018-12-26 | 2019-03-12 | 广东养慕特殊医用食品有限公司 | A kind of anti-trioxypurine peptide solid beverage, Preparation method and use |
| CN109452521B (en) * | 2018-12-26 | 2022-05-17 | 广东养慕特殊医用食品有限公司 | Auxiliary uric acid peptide reducing solid beverage, preparation method and application |
| CN109770141A (en) * | 2019-03-08 | 2019-05-21 | 唐凯 | A kind of drink eaten suitable for the high crowd of uric acid |
| CN109938349A (en) * | 2019-03-29 | 2019-06-28 | 宁波御坊堂生物科技有限公司 | A kind of oligomeric peptide functional food and preparation method thereof |
| CN110038119A (en) * | 2019-04-28 | 2019-07-23 | 杭州泽健医药科技有限公司 | A kind of pharmaceutical composition with anti-trioxypurine and antifatigue effect |
| CN110101656A (en) * | 2019-05-20 | 2019-08-09 | 江苏西宏生物医药有限公司 | A kind of preparation method of citric acid saline solution |
| CN110604316A (en) * | 2019-10-30 | 2019-12-24 | 山东若尧特医食品有限公司 | Protein solid preparation and preparation method thereof |
| CN112544974A (en) * | 2020-12-31 | 2021-03-26 | 汤臣倍健股份有限公司 | Composition with function of regulating uric acid metabolism and application thereof |
| CN113100443A (en) * | 2021-05-17 | 2021-07-13 | 卢静 | Composition and soft capsule for relieving gout and preparation method thereof |
| CN114947124A (en) * | 2022-04-22 | 2022-08-30 | 北京恒生药业有限公司 | Solid composition with gout relieving effect and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106805234A (en) | A kind of anti-trioxypurine food compositions | |
| CN101530196B (en) | Food formula of special diet containing oligopeptides for postoperative patient | |
| CN107927797A (en) | It is a kind of to eat the wholefood formula containing small peptide for muscle decay syndrome crowd | |
| CN101530195A (en) | Food formula of special diet containing oligopeptides for maternity patient | |
| CN107440107A (en) | It is a kind of to eat the food formula of special diet containing small peptide for pregnancy reaction crowd | |
| CN106723084A (en) | Soybean oligopeptide drink and preparation method and the application in spy doctor's formula food | |
| CN106579345A (en) | Total nutrient formula containing marine active substances for FSMP (foods for special medical purpose) and preparation method of total nutrient formula | |
| WO2018145664A1 (en) | Anti-fatigue composition for use in improving endurance performance | |
| CN104544116A (en) | Preparation method of special dietary protein powder suitable for pregnant women | |
| CN104855994A (en) | Non-full nutritional formula food for patients with nephropathy | |
| CN108095072A (en) | Small peptide spy's dietary seafood formula is eaten for long-term bed and muscle attenuation syndrome crowd | |
| CN104172186A (en) | Convenient food capable of conditioning liver tumor | |
| CN102048225B (en) | Red-date health protection beverage capable of improving growing development | |
| CN105614228A (en) | Chenopodium quinoa willd multi-vitamin nutrition powder processing method | |
| CN104855997A (en) | Non-whole nutrient formula food for osteoporosis | |
| CN113615783A (en) | Yak collagen peptide sports drink | |
| CN101185706B (en) | Hippophae rhamnoides nutrition mixture with delaying senility function and preparation technique thereof | |
| CN105878397A (en) | Composition capable of regulating transportation stress of cattle and sheep | |
| CN102233025A (en) | Sucrose-free traditional Chinese medicinal antialcoholic beverage rich in nutrition | |
| CN104855972A (en) | Non-full-nutrient formula food for menopause delaying and regulation of females | |
| CN105166901A (en) | Nutrient composition for hemodialysis patient | |
| CN101530227A (en) | Houttuynia cordata thunb rosa roxburghii tratt. beverage | |
| CN103431396A (en) | Natural plant buccal tablet for and preparation technique thereof | |
| CN103721262A (en) | Preparation type of manganese-zinc-selenium supplement and beverage preparation method thereof | |
| CN102266043A (en) | Novel production technology of nutrient health Rosa roxburghii solid beverage |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170609 |
|
| RJ01 | Rejection of invention patent application after publication |